IDEAYA reports preliminary $511M cash; ATM facility update with $222.5M remaining

IDEAYA Biosciences, Inc.

Preliminary cash, cash equivalents and marketable securities of $511.1M as of Sept 30, 2023 (unaudited, subject to change).
Sold 1,036,421 shares under ATM facility at weighted avg price of $26.27 between July 1 and Oct 20, 2023.
Remaining capacity under ATM facility: approximately $222.5M as of Oct 20, 2023.
ATM program originally authorized up to $250M, entered into in June 2023.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.